MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) (MTACU) has a PEG ratio of -34.25, below the sector sector average of 6.6.
Get informed when a big investor buys or sells
+ Follow-34.25
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for MTACU is -34.25. That is below the sector sector average of 6.6. Investors often review this figure alongside MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, MTACU currently prints -34.25 for PEG ratio, while the sector average sits near 6.6. That is roughly 618.8% below the sector mean. Large gaps often invite a closer look at MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s growth, margins, and balance sheet.
A PEG ratio of -34.25 for MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) is not 'good' or 'bad' on its own. Compare it with the peer average (6.6) and with MTACU's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting MTACU's PEG ratio (-34.25), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.